Background: Rathke cleft cysts (RCCs) are common benign skull-base lesions arising from embryologic remnants of Rathke pouch. Though frequently asymptomatic, RCCs can become symptomatic because of compression of adjacent neural structures. Transcranial and neuroendoscopic surgical treatments have been described for symptomatic RCCs, but recurrence rates remain as high as 30%. Bioabsorbable steroid-eluting (BASE) stents significantly decrease adhesions and recurrent ostia obstruction after endoscopic sinus surgery. We sought to use BASE stents to aid marsupialization of symptomatic RCCs.
Objective: To present long-term results of our initial experience with endoscopic-endonasal fenestration and placement of BASE stents for RCCs.
Methods: Patients undergoing neuroendoscopic transsphenoidal fenestration of RCCs with BASE stent placement were identified and their medical records retrospectively reviewed.
Results: Four patients underwent neuroendoscopic transsphenoidal fenestration and BASE stent placement from March 2016 to April 2018 for symptomatic RCCs. After the cyst contents were evacuated, a BASE stent was deployed in the cyst fenestration to prevent cyst wall regrowth or closure and facilitate marsupialization to the sphenoid sinus. No perioperative complications were encountered, and all patients reported symptom resolution by 2 weeks postoperatively. Postoperative endoscopic evaluation demonstrated epithelization of the cyst wall opening and patent marsupialization into the sphenoid sinus in all cases. After a mean follow-up of 56 ± 12 months, all patients remained asymptomatic with baseline visual function and no radiographic evidence of recurrence.
Conclusion: Bioabsorbable steroid-eluting stent placement is a safe, facile, viable augmentation of neuroendoscopic technique for symptomatic RCCs with the potential to reduce long-term recurrence rates.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1227/ons.0000000000000543 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Navigation-assisted endoscopic U-flap technique and steroid-eluting stent for choanal atresia repair.
Int J Pediatr Otorhinolaryngol
January 2025
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address:
Objectives: Surgery is the only treatment for congenital choanal atresia (CCA). It is crucial to avoid postoperative restenosis or re-occlusion of the neo-choana. This study investigated the efficacy of a navigation-assisted endoscopic endonasal U-flap technique and a bioabsorbable steroid-eluting stent for CCA repair.
View Article and Find Full Text PDFLate meningitis and a nonabsorbable stent in recurrent Rathke's cleft cyst: illustrative case.
J Neurosurg Case Lessons
September 2024
Neurosurgery, Università Cattolica del Sacro Cuore, Rome, Italy.
Background: The management of recurrent Rathke's cleft cysts (RCCs) remains challenging. The off-label application of steroid-eluting bioabsorbable or nonabsorbable intracystic stents has been recently described. Early outcomes and complications of this treatment have been described as well, but long-term data are lacking.
View Article and Find Full Text PDFChoanal atresia: a review of contemporary treatment strategies.
Curr Opin Otolaryngol Head Neck Surg
December 2024
Department of Pediatric Otolaryngology-Head and Neck Surgery, CHRISTUS Children's Hospital, Baylor College of Medicine, San Antonio, Texas, USA.
Article Synopsis
- Choanal atresia (CA) is a serious congenital issue that may need immediate surgery, with endoscopic techniques becoming the standard approach, although up to 50% of cases can experience restenosis requiring further surgery.
- Recent advancements include the use of bioabsorbable, steroid-eluting stents that have been adapted for CA since 2017, showing promising results without complications or restenosis.
- Ongoing research on these stents raises hope for better surgical outcomes in CA repairs, but more studies are needed to confirm their safety and effectiveness.
A Modified Single-Stage Endoscopic Repair for Bilateral Choanal Atresia.
Laryngoscope
October 2024
Division of Pediatric Otolaryngology, Rady Children's Hospital-San Diego, San Diego, California, U.S.A.
The work illustrates a step-by-step surgical approach to demonstrate technical feasibility of a single-stage endoscopic repair for bilateral choanal atresia with adjuvant bioabsorbable steroid-eluting stent placement to safely mitigate unique perioperative challenges in the pediatric population. Laryngoscope, 134:4414-4417, 2024.
View Article and Find Full Text PDFAssessing the effect of absorbable steroid sinus implant: a state-of-the-art systematic review.
Eur Arch Otorhinolaryngol
August 2024
ENT Department, Rhinology and Skull Base Unit, Hospital Clinic, Barcelona University, IDIBAPS, CIPERES, Barcelona, Spain.
Objectives: Endoscopic sinus surgery is not a definitive treatment for chronic rhinosinusitis (CRS). The use of sinus stents after surgery to maintain sinus patency and deliver local steroids has gained popularity. The first steroid-eluting bioabsorbable implant (SEBI) approved for this indication, later Propel, was developed in 2011.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!